The matter was identified as cellulosic fibers and/or plastic. If infused, the matter could trigger both chronic and acute reactions and could potentially be life-threatening, according to a news release.
Baxter received four complaints in six months from customers who saw the particulate matter before administering the solution to a patient, according to the news release.
The pharmaceutical company is recalling three lots of sodium chloride injection and one lot of potassium chloride injection. The lots were distributed worldwide between February 2013 and June 2014.
Baxter is one of the pharmaceutical companies working with the U.S. Food and Drug Administration to help alleviate the saline solution shortage, even temporarily importing solution from its manufacturing facility in Spain.
More Articles on the Saline Shortage:
Navigating the Saline Solution Shortage: 4 Things to Know
FDA Works to Ease National Saline Shortage
Hospitals Running Low on IV Fluid
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
